CARDIAC ALLOGRAFT VASCULOPATHY: CURRENT REVIEW

被引：0
|
作者：
Mironkov, B. L. [1 ]
Uvarova, D. D. [1 ]
Koloskova, N. N. [1 ]
Sapronova, Yu. V. [1 ]
Muminov, I. I. [1 ]
Yusova, A. A. [1 ]
Sakhovsky, S. A. [1 ]
机构：
[1] Shumakov Natl Med Res Ctr Transplantol & Artifici, Moscow, Russia
来源：
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV | 2024年 / 26卷 / 02期
关键词：
cardiac allograft vasculopathy; heart transplantation; HEART-TRANSPLANT RECIPIENTS; PROGRESSION; PREVENTION;
D O I：
10.15825/1995-1191-2024-2-42-47
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
Transplant coronary artery disease (TCAD) is one of the main causes of graft dysfunction and graft loss. Early diagnosis and treatment of cardiac allograft vasculopathy (CAV) can increase graft survival and improve the prognosis for heart transplant recipients. This review presents current data on the problem of CAV, its pathogenesis and the main factors influencing the course of this disease.
引用
收藏
页码：42 / 47
页数：6
相关论文
共 50 条
  • [21] Declining Incidence of Cardiac Allograft Vasculopathy: A Serial Angiographic Review
    Khan, R.
    Morant, K.
    Pflugfelder, P. W.
    Kostuk, W. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S173 - S173
  • [22] DECLINING INCIDENCE OF CARDIAC ALLOGRAFT VASCULOPATHY: A SERIAL ANGIOGRAPHIC REVIEW
    Khan, R.
    Morant, K.
    Pflugfelder, P.
    Kostuk, W.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S225 - S225
  • [23] CARDIAC ALLOGRAFT VASCULOPATHY AFTER CARDIAC TRANSPLANTATION
    WEIS, M
    HARTMANN, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (39) : 1327 - 1333
  • [24] CARDIAC ALLOGRAFT HYPERTROPHY: AN IMPORTANT PROGNOSTIC MARKER FOR CARDIAC ALLOGRAFT VASCULOPATHY
    Yerebakan, Halit
    Ji, Mengxi
    Ross, Alexandra
    Jiang, Jeffrey
    Jones, Sophie
    Soni, Lori
    Argenziano, Michael
    Smith, Craig
    Takayama, Hiroo
    Naka, Yoshifumi
    Schulze, P. Christian
    Cheema, Faisal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E927 - E927
  • [25] Cardiac Allograft Hypertrophy: An Important Prognostic Marker for Cardiac Allograft Vasculopathy
    Yerebakan, H.
    Ji, M.
    Ross, A.
    Jiang, J.
    Jones, S.
    Soni, L.
    Argenziano, M.
    Smith, C. R.
    Takayama, H.
    Naka, Y.
    Schulze, P. C.
    Cheema, F. H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S228 - S228
  • [26] Adiponectin in Cardiac Allograft Vasculopathy.
    Goparaju, S.
    Dvorina, N.
    Wang, X.
    Yu, H.
    Baldwin, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 319 - 319
  • [27] Coronary stenting in cardiac allograft vasculopathy
    Jain, SP
    Ramee, SR
    White, CJ
    Mehra, MR
    Ventura, HO
    Zhang, SY
    Jenkins, JS
    Collins, TJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (06) : 1636 - 1640
  • [28] A Novel Definition of Cardiac Allograft Vasculopathy
    Eisen, H. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (10) : 2571 - 2572
  • [29] Cardiac allograft vasculopathy - the cellular attack
    Hutchinson, IV
    ZEITSCHRIFT FUR KARDIOLOGIE, 2000, 89 : 16 - 20
  • [30] Perspectives on cardiac allograft vasculopathy.
    Young J.B.
    Current Atherosclerosis Reports, 2000, 2 (3) : 259 - 271
12345